| Jonathan David Schettler, | |
|
709 W Main St, Manchester, IA 52057-1526 | |
| (563) 927-3232 | |
| Not Available |
| Full Name | Jonathan David Schettler |
|---|---|
| Gender | Male |
| Speciality | Certified Registered Nurse Anesthetist (crna) |
| Experience | 9 Years |
| Location | 709 W Main St, Manchester, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1760722573 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | D117493 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Pella Regional Health Center | Pella, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Anesthesia Iowa Plc | 3476443524 | 8 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has sold the worldwide rights to its molecular chaperone assets to privately-held, Copenhagen, Denmark-based Orphazyme ApS.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
HRA Pharma announced today that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive.
Seeing animals up close is an integral part of experiencing the state and county fairs that take place around the country each summer and fall. And with good hygiene, Kansas State University veterinary experts say fair visitors shouldn't worry about contracting diseases from animals.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
› Verified 7 days ago
| Entity Name | Delaware County Memorial Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1982667929 PECOS PAC ID: 2062316375 Enrollment ID: O20031119000881 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has sold the worldwide rights to its molecular chaperone assets to privately-held, Copenhagen, Denmark-based Orphazyme ApS.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
HRA Pharma announced today that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive.
Seeing animals up close is an integral part of experiencing the state and county fairs that take place around the country each summer and fall. And with good hygiene, Kansas State University veterinary experts say fair visitors shouldn't worry about contracting diseases from animals.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
› Verified 7 days ago
| Entity Name | Anesthesia Iowa Plc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1114018983 PECOS PAC ID: 3476443524 Enrollment ID: O20040319001199 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has sold the worldwide rights to its molecular chaperone assets to privately-held, Copenhagen, Denmark-based Orphazyme ApS.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
HRA Pharma announced today that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive.
Seeing animals up close is an integral part of experiencing the state and county fairs that take place around the country each summer and fall. And with good hygiene, Kansas State University veterinary experts say fair visitors shouldn't worry about contracting diseases from animals.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathan David Schettler, 709 W Main St, Manchester, IA 52057-1526 Ph: (563) 927-3232 | Jonathan David Schettler, 709 W Main St, Manchester, IA 52057-1526 Ph: (563) 927-3232 |
News Archive
CytRx Corporation, a biopharmaceutical company specializing in oncology, today announced that it has sold the worldwide rights to its molecular chaperone assets to privately-held, Copenhagen, Denmark-based Orphazyme ApS.
Scientists are reporting development of a process for producing large quantities of a much-needed new imaging agent for computed tomography scans in heart disease, breast cancer and other diseases, and the first evidence that the material is safe for clinical use.
HRA Pharma announced today that the U.S. Food and Drug Administration's (FDA) Advisory Committee for Reproductive Health Drugs voted 11 to 0 that the company's application provided sufficient information to conclude that ulipristal acetate is effective and safe for use as an emergency contraceptive.
Seeing animals up close is an integral part of experiencing the state and county fairs that take place around the country each summer and fall. And with good hygiene, Kansas State University veterinary experts say fair visitors shouldn't worry about contracting diseases from animals.
Lantheus Medical Imaging, Inc., a worldwide leader in diagnostic medical imaging, today announced preliminary data from a single site participating in the multicenter Phase 2 clinical trial that showed that Positron Emission Tomography (PET) imaging with its novel investigational agent flurpiridaz F 18 injection (formerly known as BMS747158) provided better image quality than technetium-99m sestamibi single photon emission computed tomography (SPECT), the current standard for the non-invasive detection of coronary artery disease (CAD).
› Verified 7 days ago
Isaac Albert Butler, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 712 W Main St, Manchester, IA 52057 Phone: 563-822-1435 | |
David Mark Huether, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 17893 224th St, Manchester, IA 52057 Phone: 563-927-6183 Fax: 563-927-6183 | |
James Oliver Cody, Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 712 W Main St, Manchester, IA 52057 Phone: 563-822-1435 | |
Travis Randal Schulze, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 712 W Main St, Manchester, IA 52057 Phone: 563-822-1435 Fax: 563-822-1436 | |
Ms. Anne Meyer-mccright, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 712 W Main St, Manchester, IA 52057 Phone: 563-822-1435 Fax: 563-822-1436 | |
Seth Nicolas Additon, DNP, CRNA Nurse Anesthetist - CR Medicare: Medicare Enrolled Practice Location: 712 W Main St, Manchester, IA 52057 Phone: 563-822-1435 | |
Mr. Mark G Odden, CRNA Nurse Anesthetist - CR Medicare: Accepting Medicare Assignments Practice Location: 17893 224th St, Manchester, IA 52057 Phone: 563-927-6183 Fax: 563-927-6183 |